Synflorix™ (10-valent pneumococcal conjugate vaccine; GlaxoSmithKline Biologicals, Belgium) has been investigated globally to evaluate immunogenicity, safety and reactogenicity with different ...
GlaxoSmithKline has submitted a regulatory application to the European Medicines Agency (EMA) seeking approval of an additional indication for Synflorix in the European Union (EU). This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback